Pricing Log in Create free account

Absci Corporation (ABSI) vs Immunocore Holdings PLC Sponsored ADR (IMCR)

Absci Corporation and Immunocore Holdings PLC Sponsored ADR are both Biotechnology companies. Absci Corporation and Immunocore Holdings PLC Sponsored ADR are of similar size ($1.5B and $1.5B). Immunocore Holdings PLC Sponsored ADR grew revenue faster over the last twelve months: 21.0% against −62.3%. Immunocore Holdings PLC Sponsored ADR has the higher net margin (−4.20% vs −7,756.4%) and the higher return on invested capital (0.00% vs −174.7%). Across the 18 metrics below, Immunocore Holdings PLC Sponsored ADR leads on 14 and Absci Corporation on 4.

Valuation

Metric ABSI IMCR Biotechnology median
P/E n/m n/m 8.50
P/S 832.25 3.48 9.71
P/B 5.28 3.57 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 703.53 2.46 9.21
Earnings yield (9.70%) (1.22%) (33.15%)
Free cash flow yield (8.37%) (2.75%) (25.50%)

Profitability

Metric ABSI IMCR Biotechnology median
Gross margin 100.00% 98.90% 65.16%
Operating margin (8,084.50%) (5.24%) 0.00%
Net margin (7,756.37%) (4.20%) 0.00%
Free cash flow margin (6,969.83%) (9.55%) 0.00%
Return on equity (57.72%) (4.47%) (56.36%)
Return on assets (50.57%) (1.64%) (48.04%)
Return on invested capital (174.74%) 0.00% 0.00%

Growth

Metric ABSI IMCR Biotechnology median
Revenue growth (TTM) (62.28%) 20.95% 6.02%
EPS growth (last fiscal year) 10.64% 30.39% 30.26%
Revenue growth, 5-year CAGR (10.14%) 59.57% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABSI IMCR Biotechnology median
Debt to equity 0.00 0.94 0.00
Current ratio 10.63 4.47 4.72
Net debt to EBITDA 1.32 11.19 0.96

Dividend

Metric ABSI IMCR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ABSI IMCR Biotechnology median
Market cap 1.52b 1.52b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack